Update on respiratory infection caused by Bordetella parapertussis

Pediatric Infectious Disease Journal

Volumn 18, Issue 4, 1999, Pages 375-381

  Hoppe, Jörg E ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Bordetella parapertussis; Bordetella pertussis; Parapertussis; Pertussis

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CEFOTAXIME; CEFPIROME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CHLORAMPHENICOL; CIPROFLOXACIN; CLARITHROMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; GREPAFLOXACIN; HMR 3004; IMIPENEM; JOSAMYCIN; LEVOFLOXACIN; MACROLIDE; MEROPENEM; MINOCYCLINE; MOXIFLOXACIN; OFLOXACIN; PIPERACILLIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RIFAMPICIN; ROXITHROMYCIN; TELITHROMYCIN; TETRACYCLINE; TROVAFLOXACIN; UNINDEXED DRUG;

BACTERIAL VIRULENCE; BACTERIUM ISOLATION; BORDETELLA PARAPERTUSSIS; BRONCHITIS; CLINICAL FEATURE; MINIMUM INHIBITORY CONCENTRATION; PERTUSSIS; PRIORITY JOURNAL; RESPIRATORY TRACT INFECTION; REVIEW;

EID: 0032940136     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-199904000-00016     Document Type: Review

References (70)

1. Anonymous. From wimp to pathogen. ASM News 1989;55:10.
2. Lautrop H. Epidemics of parapertussis. Lancet 1971;1: 1195-8.
3. Heininger U, Stehr K, Schmitt-Grohé S, et al. Clinical characteristics of illness caused by Bordetella parapertussis compared with illness caused by Bordetella pertussis. Pediatr Infect Dis J 1994;13:306-9.
4. Mastrantonio P, Stefanelli P, Giuliano M, et al. Bordetella parapertussis infection in children: epidemiology, clinical symptoms, and molecular characteristics of isolates. J Clin Microbiol 1998;36:999-1002.
5. Mastrantonio P, Giuliano M, Stefanelli P, et al. Bordetella parapertussis infections. In: Brown F, Greco D, Mastrantonio P, Salmaso S, Wassilak S, eds. Pertussis vaccine trials. Dev Biol Stand 1997;89:255-9.
6. Reizenstein E, Johansson B, Mardin L, Abens J, Möllby R, Hallander HO. Diagnostic evaluation of polymerase chain reaction discriminative for Bordetella pertussis, B. parapertussis, and B. bronchiseptica. Diagn Microbiol Infect Dis 1993;17:185-91.
7. Li Z, Jansen DL, Finn TM, et al. Identification of Bordetella pertussis infection by shared-primer PCR. J Clin Microbiol 1994;32:783-9.
8. Van der Zee A, Agterberg C, Peeters M, Schellekens J, Mooi FR. Polymerase chain reaction assay for pertussis: simultaneous detection and discrimination of Bordetella pertussis and Bordetella parapertussis. J Clin Microbiol 1993;31:2134-40.
9. Van der Zee A, Agterberg C, Peeters M, Mooi F, Schellekens J. A clinical validation of Bordetella pertussis and Bordetella parapertussis polymerase chain reaction: comparison with culture and serology using samples from patients with suspected whooping cough from a highly immunized population. J Infect Dis 1996;174:89-96.
10. Lind-Brandberg L, Welinder-Olsson C, Lagergard T, Taranger J, Trollfors B, Zackrisson G. Evaluation of PCR for diagnosis of Bordetella pertussis and Bordetella parapertussis infections. J Clin Microbiol 1998;36:679-83.
11. Linnemann CC Jr, Perry EB. Bordetella parapertussis. Am J Dis Child 1977;131:560-3.
12. Eldering G, Kendrick P. A group of cultures resembling both Bacillus pertussis and Bacillus bronchisepticus but identical with neither [Abstract]. J Bacteriol 1937;33:71.
13. Eldering G, Kendrick P. Bacillus para-pertussis: a species resembling both Bacillus pertussis and Bacillus bronchisepticus but identical with neither. J Bacteriol 1938;35:561-72.
14. Bradford WL, Slavin B. An organism resemblingHemophilus pertussis. Am J Pub Health 1937;27:1277-82.
15. Hoppe JE. Bordetella. chap 40. Manual of clinical microbiology, 7th ed. Washington, DC: American Society for Microbiology (in press).
16. Kloos WE, Mohapatra N, Dobrogosz WJ, Ezzell JW, Manclark CR. Deoxyribonucleotide sequence relationships among Bordetella species. Int J Syst Bacteriol 1981;31:173-6.
17. Musser JM, Hewlett EL, Peppler MS, Selander RK. Genetic diversity and relationships in populations of Bordetella spp. J Bacteriol 1986;166:230-7.
18. Weiss AA. The genus Bordetella. chap 127. In: Balows A, Trüper HG, Dworkin M, Harder W, Schleifer KH, eds. The prokaryotes: a handbook on the biology of bacteria. 2nd ed. Berlin: Springer, 1992:2530-43.
19. Rappuoli R, Gross R, Aricò B. Conversion from Bordetella parapertussis to B. pertussis [Letter]. Lancet 1987;2:511.
20. Khelef N, Danve B, Quentin-Millet MJ, Guiso N. Bordetella pertussis and Bordetella parapertussis: two immunologically distinct species. Infect Immun 1993;61:486-90.
21. Vancanneyt M, Vandamme P, Kersters K. Differentiation of Bordetella pertussis, B. parapertussis, and B. bronchiseptica by whole-cell protein electrophoresis and fatty acid analysis. Int J Syst Bacteriol 1995;45:842-7.
22. Kumazawa NH, Yoshikawa M. Conversion of Bordetella pertussis to Bordetella parapertussis. J Hyg 1978;81:15-23.
23. Granström M, Askelöf P. Parapertussis: an abortive pertussis infection? Lancet 1982;2:1:249-50.
24. Aricò B, Rappuoli R. Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol 1987;169:2847-53.
25. Marchitto KS, Smith SG, Locht C, Keith JM. Nucleotide sequence homology to pertussis toxin gene in Bordetella bronchiseptica and Bordetella parapertussis. Infect Immun 1987:55:497-501.
26. Ewanowich CA, Sherburne RK, Man SFP, Peppler MS. Bordetella parapertussis invasion of HeLa 229 cells and human respiratory epithelial cells in primary culture. Infect Immun 1989;57:1240-7.
27. Van der Zee A, Groenendijk H, Peeters MM, Mooi FR. The differentiation of Bordetella parapertussis and Bordetella bronchiseptica from humans and animals as determined by DNA polymorphism mediated by two different insertion sequence elements suggests their phylogenetic relationship. Int J Syst Bacteriol 1996;46:640-7.
28. Porter JF, Connor K, Donachie W. Differentiation between human and ovine isolates of Bordetella parapertussis using pulsed-field gel electrophoresis. FEMS Microbiol Lett 1996; 135:131-5.
29. Eldering G, Kendrick PL. Incidence of parapertussis in the Grand Rapids area as indicated by 16 years' experience with diagnostic cultures. Am J Pub Health 1952;42:27-31.
30. Vysoká B. The epidemiology of pertussis and parapertussis. J Hyg Epidemiol Microbiol Immunol 1958;2:196-204.
31. Wirsing von König CH, Finger H. Role of pertussis toxin in causing symptoms of Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis 1994;13:455-8.
32. Lautrop H. Observations on parapertussis in Denmark, 1950-1957. Acta Pathol Microbiol Scand 1958;43:255-66.
33. Donchev D, Stoyanova M. The epidemiological significance of the differentiation of pertussis and parapertussis. J Hyg Epidemiol Microbiol Immunol 1961;5:294-7.
34. Nordmann P, Francois B, Menozzi FD, Commare MC, Barois A. Whooping cough associated with Bordetella parapertussis in a human immunodeficiency virus-infected child [Letter]. Pediatr Infect Dis J 1992;11:248.
35. Taneff I, Scheljaskoff S, Schtereff P, Todoroff M, Bojadjiewa M, Awramoff S. Über die Parapertussis. Neue Osterr Z Kinderheilkd 1960;5:254-8.
36. He Q, Edelman K, Arvilommi H, Mertsola J. Protective role of immunoglobulin G antibodies to filamentous hemagglutinin and pertactin of Bordetella pertussis in Bordetella parapertussis infection. Eur J Clin Microbiol Infect Dis 1996;15:793-8.
37. Miller JJ Jr, Saito TM, Silverberg RJ. Parapertussis. J Pediatr 1941;19:229-40.
38. Taranger J, Trollfors B, Lagergard T, Zackrisson G. Parapertussis infection followed by pertussis infection [Letter]. Lancet 1994;344:1703.
39. Vysoká-Burianová B. Contemporary problems in the epidemiology of whooping cough. J Hyg Epidemiol Microbiol Immunol 1963;7:472-81.
40. Mertsola J. Mixed outbreak of Bordetella pertussis and Bordetella parapertussis infection in Finland. Eur J Clin Microbiol 1985;4:123-8.
41. Nelson WL, Hopkins RS, Roe MH, Glode MP. Simultaneous infection with Bordetella pertussis and respiratory syncytial virus in hospitalized children. Pediatr Infect Dis 1986;5: 540-4.
42. Davis SF, Sutter RW, Strebel PM, et al. Concurrent outbreaks of pertussis and Mycoplasma pneumoniae infection: clinical and epidemiological characteristics of illnesses manifested by cough. Clin Infect Dis 1995;20:621-8.
43. Wirsing von König CH, Rott H, Bogaerts H, Schmitt HJ. A serologic study of organisms possibly associated with pertussis-like coughing. Pediatr Infect Dis J 1998;17:64566-9.
44. Hennecke C. Untersuchungen über Parapertussis. Monatssehr Kinderheilkd 1966;114:33-8.
45. Simon C. Parapertussis. Deut Med Wochenschr 1964;89: 1733-9.
46. Flosdorf EW, Bondi A, Felton H, McGuiness AC. Studies with Hemophilus pertussis. J Pediatr 1942;21:625-34.
47. Borska K, Simkovicová M. Studies on the circulation of Bordetella pertussis and Bordetella parapertussis in populations of children. J Hyg Epidemiol Microbiol Immunol 1972; 16:159-72.
48. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280:635-7.
49. Müller FMC, Hoppe JE, Wirsing von König CH. Laboratory diagnosis of pertussis: state of the art in J Clin Microbiol 1997;1997;35:2435-43.
50. Connor KM, Porter JF, Quirie MM, Donachie W. Moredun Bordetella medium, an improved selective medium for isolation of Bordetella parapertussis. J Clin Microbiol 1996;34: 638-40.
51. Lautrop H. Laboratory diagnosis of whooping cough or Bordetella infections. Bull World Health Organ 1960;23:15-35.
52. Meade BD, Mink CM, Manclark CR. Serodiagnosis of pertussis. In: Manclark CR, ed. Proceedings of the Sixth International Symposium on Pertussis, no. (FDA) 90-1165. Washington, DC, Department of Health and Human Services, 1990:322-9.
53. Hallander HO, Storsaeter J, Möllby R. Evaluation of serology and nasopharyngeal cultures for diagnosis of pertussis in a vaccine efficacy trial. J Infect Dis 1991;163:1046-54.
54. Hoppe JE. State of the art in antibacterial susceptibility of Bordetella pertussis and antibiotic treatment of pertussis. Infection 1998;26:242-6.
55. Hoppe JE, Tschirner T. Comparison of media for agar dilution susceptibility testing of Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis 1995;14: 775-9.
56. Hoppe JE, Paulus T. Comparison of three media for agar dilution susceptibility testing of Bordetella pertussis using six antibiotics. Eur J Clin Microbiol Infect Dis 1998;17:391-3.
57. Hoppe JE, Tschirner T. Comparison of E test and agar dilution for testing the activity of three macrolides against Bordetella parapertussis. Diagn Microbiol Infect Dis 1997;28: 49-51.
58. Day E, Bradford WI. Susceptibility of Hemophilus parapertussis to certain antibiotics. Pediatrics 1952;9:320-6.
59. Hoppe JE. Update on epidemiology, diagnosis, and treatment of pertussis. Eur J Clin Microbiol Infect Dis 1996;15:189-93.
60. Brun Y, Forey F, Gamondes JP, Tebib A, Brune J, Fleurette J. Levels of erythromycin in pulmonary tissue and bronchial mucus compared to those of amoxicillin. J Antimicrob Chemother 1981;8:459-66.
61. Hoppe JE, Halm U, Hagedorn HJ, Kraminer-Hagedorn A. Comparison of erythromycin ethylsuccinate and co-trimoxazole for treatment of pertussis. Infection 1989;17:227-31.
62. Hoppe JE, Simon CG. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to seven fluoroquinolones. Antimicrob Agents Chemother 1990;34:2287-8.
63. Hoppe JE, Rahimi-Galougahi E, Seibert G. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to four fluoroquinolones (levofloxacin, d-ofloxacin, ofloxacin, and ciprofloxacin), cefpirome, and meropenem. Antimicrob Agents Chemother 1996;40:807-8.
64. Hoppe JE, Dalhoff A, Pfründer D. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to BAY 12-8039, trovafloxacin, and ciprofloxacin. Antimicrob Agents Chemother 1998;42:1868.
65. Hoppe JE. In vitro activities of grepafloxacin, moxifloxacin, ciprofloxacin, and clarithromycin against Bordetella pertussis and Bordetella parapertussis [Abstract E-212b]. Presented at the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy, San Diego, September 24 to 27, 1998.
66. Kurzynski TA, Boehm DM, Rott-Petri JA, Schell RF, Allison PE. Antimicrobial susceptibilities of Bordetella species isolated in a multicenter pertussis surveillance project. Antimicrob Agents Chemother 1988;32:137-40.
67. Watanabe M, Haraguchi Y. In vitro susceptibility of Bordetella parapertussis to various antimicrobial agents. Antimicrob Agents Chemother 1989;33:968-9.
68. Hoppe JE, Eichhorn A. Activity of new macrolides against Bordetella pertussis and Bordetella parapertussis. Eur J Clin Microbiol Infect Dis 1989;8:653-4.
69. Hoppe JE, Bryskier A. In vitro susceptibilities of Bordetella pertussis and Bordetella parapertussis to two ketolides (HMR 3004 and HMR 3647), four macrolides (azithromycin, clarithromycin, erythromycin A, and roxithromycin), and two ansamycins (rifampin and rifapentine). Antimicrob Agents Chemother 1998;42:965-6.
70. Hoppe JE, Haug A, Botzenhart K. Susceptibility of Bordetella pertussis and Bordetella parapertussis to twenty-four antibiotics. Chemotherapy 1987;33:250-4.